Article
Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black Adults.
Circulation. Genomic and precision medicine - 1 Dec 2021
Olson Nels C, Raffield Laura M, Moxley Anne H, Miller-Fleming Tyne W, Auer Paul L, Franceschini Nora, Ngo Debby, Thornton Timothy A, Lange Ethan M, Li Yun, Nickerson Deborah A, Zakai Neil A, Gerszten Robert E, Cox Nancy J, Correa Adolfo, Mohlke Karen L, Reiner Alexander P
Abstract excerpt
BACKGROUND: suPAR (Soluble urokinase plasminogen activator receptor) has emerged as an important biomarker of coagulation, inflammation, and cardiovascular disease (CVD) risk. The contribution of suPAR to CVD risk and its genetic influence in Black populations have not been evaluated. METHODS: We measured suPAR in 3492 Black adults from the prospective, community-based JHS (Jackson Heart Study). Cross-sectional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
